Date: | |
Time: | |
Webcast: | Click Here |
To schedule a 1x1 meeting with the Company, please contact your Jefferies representative.
About
Investor Relations:
T: 212-452-2793
E: lwilson@insitecony.com
Source:
![](https://ml.globenewswire.com/media/Mzg0YzBiMzYtYjIxNy00ODQzLTlkN2QtZTg3ZjQyZWEwNjAyLTEwMzA4MzM=/tiny/ANI-Pharmaceuticals-Inc-.png)
2024 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
61.44 USD | +1.02% |
|
-3.52% | +11.43% |
02/07 | ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets | MT |
02/07 | ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP | CI |
Date: | |
Time: | |
Webcast: | Click Here |
To schedule a 1x1 meeting with the Company, please contact your Jefferies representative.
About
Investor Relations:
T: 212-452-2793
E: lwilson@insitecony.com
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
+11.43% | 119.25Cr | |
+56.89% | 82TCr | |
+39.52% | 63TCr | |
-6.55% | 35TCr | |
+15.99% | 32TCr | |
+7.92% | 30TCr | |
+13.74% | 24TCr | |
+13.83% | 22TCr | |
-0.49% | 22TCr | |
+7.94% | 17TCr |